melatonin/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on psoriasis Area and Severity Index (PASI) score
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.FindingNull result“Although the PASI score in the melatonin and rosuvastatin groups compared with placebo decreased, the changes were not significant.”
Quoted verbatim from Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double-blinded clinical trial.. - Study
- RCT
- Dose
- melatonin cream 5.0% (w/w) applied twice a day
- Population
- adults with mild-to-moderate plaque psoriasis; melatonin cream 5% w/w vs placebo cream, applied twice daily for 8 weeks
Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double-blinded clinical trial.2024PMID:38563131Permalink
Keep reading
- Everything the graph holds on melatonin
- Every compound studied against Psoriasis Area and Severity Index (PASI) score
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M3R5A77BJRTPZNGCPA2MJKTM